MK0653A, ezetimibe (+) simvastatin

DRUG4 trials

Sponsors

Organon and Co

Conditions

HypercholesterolemiaType 2 Diabetes Mellitus

Phase 3

Study to Evaluate the Cholesterol Lowering Effects of Two Marketed Drugs in Patients With Elevated Cholesterol Levels (0653A-058)

CompletedNCT00090298

Organon and CoHypercholesterolemia

Start: 2004-04-30End: 2004-12-31Updated: 2024-08-15

A Study of MK0653A (Ezetimibe (+) Simvastatin) in Patients With Hypercholesterolemia (0653A-038)

CompletedNCT00092651

Organon and CoHypercholesterolemia

Start: 2002-09-30End: 2003-06-30Updated: 2024-08-23

MK0653A (Ezetimibe (+) Simvastatin) Compared to an Approved Drug (Atorvastatin) for the Treatment of High Cholesterol (0653A-051)(COMPLETED)

CompletedNCT00092690

Organon and CoHypercholesterolemia

Start: 2003-06-30End: 2004-03-31Updated: 2024-05-10

A Multicenter Study to Evaluate the Cholesterol Lowering Effects of Two Marketed Products in Patients With Type 2 Diabetes Mellitus and Hypercholesterolemia (MK-0653A-077)

CompletedNCT00110435

Organon and CoHypercholesterolemia, Type 2 Diabetes Mellitus

Start: 2005-05-31End: 2005-12-31Updated: 2024-08-15